TDWD Tailwind releases its latest quarterly earnings report outlines new core strategic expansion priorities How does Cohen PTA PS compare Buying Pressure 20260429 CRAC CrownReserve quarterly earnings details are still pending leadership will lay out core strategic priorities at next weeks investor call OPXS Optex posts 216 revenue growth to 413M yet stock falls 14 despite strong quarter Pinterest Inc Analyst Review Highlights Platforms Strategic Positioning How Technology Is Shaping a New Era of Healthcare Innovation Cigna Group CI Downgraded to Hold by Deutsche Bank Amid MultiYear Uncertainty Signos Secures 20 Million Funding Expands Dexcom Partnership to Tap GLP1 Weight Loss Market Deutsche Bank Adjusts Equinix Price Target Amid Data Center Demand Growth Retail Investors Gain Direct Access to SpaceX Public Offering Through Major Brokerage Platforms Shell SHEL Q1 2026 Earnings Strong Earnings Beat as Margins and Operations Outperform Estimates IMMP Q1 2026 Earnings EPS Misses Estimates as Development Progress Continues Ares Management ARES Q1 2026 Earnings EPS Misses Street View but Stock Gains on Resilient Business Trends ASX Q1 2026 Earnings EPS Surpasses Estimates by 9 Stock Rises ASPS Q1 2026 Earnings EPS Exceeds Estimates by 349 Shares Surge Intergroup Corporation INTG Edges Lower as Price Tests Key Support Near 40 Mueller Industries MLI Consolidates Near 138 as Traders Eye Key Support and Resistance Kalaris Therapeutics KLRS Surges 772 as Shares Approach Key Resistance WESCO International WCC Edges Higher as Momentum Builds Above Key Support GLW Q1 2026 Earnings Small EPS Beat as Corning Delivers Profitability Focus Insperity Q1 2026 Earnings EPS Surpasses Estimates by 511 UFCS Q1 2026 Earnings Strong EPS Beat Reflects Improved Underwriting Performance RDNW Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Stock Reaction FRPT Q1 2026 Earnings Steep Earnings Miss Highlights Cost Pressures at Freshpet FOLD Q4 2025 Earnings EPS Falls Short of Estimates Stock Unchanged Markets Shift Expectations Fed Rate Hike Scenario Gains Traction After Hot Inflation Data Actuate Therapeutics Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Reports Wider Loss